Search Results - Nixon, D F

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Routine full blood counts as indicators of acute viral infections.

    Routine full blood counts as indicators of acute viral infections. by Nixon, D F, Parsons, A J, Eglin, R P

    Published 1987
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.

    Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes. by Waterfield, J D, Nixon, D F, Mair, M G

    Published 1981
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Cellular and humoral antigenic epitopes in HIV and SIV.

    Cellular and humoral antigenic epitopes in HIV and SIV. by Nixon, D F, Broliden, K, Ogg, G, Broliden, P A

    Published 1992
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Rational Peptide Selection To Detect Human Immunodeficiency Virus Type 1-Specific T-Cell Responses under Resource-Limited Conditions

    Rational Peptide Selection To Detect Human Immunodeficiency Virus Type 1-Specific T-Cell Responses under Resource-Limited Conditions by Willberg, C. B., Pillai, S. K., Sharp, E. R., Rosenberg, M. G., Agudelo, J. D., Barbour, J. D., Nixon, D. F.

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Potentially Exposed but Uninfected Individuals Produce Cytotoxic and Polyfunctional Human Immunodeficiency Virus Type 1-Specific CD8(+) T-Cell Responses Which Can Be Defined to the Epitope Level

    Potentially Exposed but Uninfected Individuals Produce Cytotoxic and Polyfunctional Human Immunodeficiency Virus Type 1-Specific CD8(+) T-Cell Responses Which Can Be Defined to the... by Erickson, A. L., Willberg, C. B., McMahan, V., Liu, A., Buchbinder, S. P., Grohskopf, L. A., Grant, R. M., Nixon, D. F.

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers.

    Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers. by Lechner, F, Sullivan, J, Spiegel, H, Nixon, D F, Ferrari, B, Davis, A, Borkowsky, B, Pollack, H, Barnes, E, Dusheiko, G, Klenerman, P

    Published 2000
    Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol

    Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from G... by Karlsson, A. C., Chapman, J. M., Heiken, B. D., Hoh, R., Kallas, E. G., Martin, J. N., Hecht, F. M., Deeks, S. G., Nixon, D. F.

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Direct Ex Vivo Measurement of CD8(+) T-Lymphocyte Responses to Human Parvovirus B19

    Direct Ex Vivo Measurement of CD8(+) T-Lymphocyte Responses to Human Parvovirus B19 by Tolfvenstam, T., Oxenius, A., Price, D. A., Shacklett, B. L., Spiegel, H. M. L., Hedman, K., Norbeck, O., Levi, M., Olsen, K., Kantzanou, M., Nixon, D. F., Broliden, K., Klenerman, P.

    Published 2001
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

    Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy by Ogg, G. S., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Hurley, A., Markowitz, M., Ho, D. D., McMichael, A. J., Nixon, D. F.

    Published 1999
    Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Skewed Distribution of Natural Killer Cells in Psoriasis Skin Lesions

    Skewed Distribution of Natural Killer Cells in Psoriasis Skin Lesions by Batista, M. D., Ho, E. L., Kuebler, P. J., Milush, J. M., Lanier, L. L., Kallas, E. G., York, V. A., Chang, D., Liao, W., Unemori, P., Leslie, K. S., Maurer, T., Nixon, D. F.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Antiviral gene expression in psoriasis

    Antiviral gene expression in psoriasis by Raposo, R.A., Gupta, R., Abdel-Mohsen, M., Dimon, M., Debbaneh, M., Jiang, W., York, V.A., Leadabrand, K.S., Brown, G., Malakouti, M., Arron, S., Kuebler, P.J., Wu, J.J., Pillai, S.K., Nixon, D.F., Liao, W.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease

    Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease by Ndhlovu, L C, Snyder-Cappione, J E, Carvalho, K I, Leal, F E, Loo, C P, bruno, F R, Jha, A R, Devita, D, Hasenkrug, A M, Barbosa, H M R, Segurado, A C, Nixon, D F, Murphy, E L, Kallas, E G

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: